OBJECTIVES: This study describes the development of a framework for health technology decisions, for Ontario Health Technology Advisory Committee (OHTAC) in Ontario, Canada. METHODS: OHTAC convened a "Decision Determinants Sub-Committee" in January 2007, which undertook a systematic literature review and conducted key informant interviews to develop an explicit decision-making framework. RESULTS: The "Decision Determinants Sub-Committee" offered recommendations about decision criteria, and the process by which decisions are made. Decision criteria include (i) overall clinical benefit, (ii) consistency with societal and ethical values, (iii) value for money, and (iv) feasibility of adoption into the health system. The decision process should be transparent and fair and should use a deliberative process in delivering recommendations. CONCLUSIONS: This methodology is currently being pilot tested in a live environment: OHTAC. It will be evaluated and revised according to its feasibility, acceptability, and perceived usefulness.
OBJECTIVES: This study describes the development of a framework for health technology decisions, for Ontario Health Technology Advisory Committee (OHTAC) in Ontario, Canada. METHODS: OHTAC convened a "Decision Determinants Sub-Committee" in January 2007, which undertook a systematic literature review and conducted key informant interviews to develop an explicit decision-making framework. RESULTS: The "Decision Determinants Sub-Committee" offered recommendations about decision criteria, and the process by which decisions are made. Decision criteria include (i) overall clinical benefit, (ii) consistency with societal and ethical values, (iii) value for money, and (iv) feasibility of adoption into the health system. The decision process should be transparent and fair and should use a deliberative process in delivering recommendations. CONCLUSIONS: This methodology is currently being pilot tested in a live environment: OHTAC. It will be evaluated and revised according to its feasibility, acceptability, and perceived usefulness.
Authors: N Sikich; S Baidobonsoo; V Costa; C Hulobowich; K Kaulback; I Nevis; S Sehatzadeh; N Sikich; L Levin; B Pham; M Krahn Journal: Ont Health Technol Assess Ser Date: 2014-12-01
Authors: Margareta Nordin; Kristi Randhawa; Paola Torres; Hainan Yu; Scott Haldeman; O'Dane Brady; Pierre Côté; Carlos Torres; Michael Modic; Rajani Mullerpatan; Christine Cedraschi; Roger Chou; Emre Acaroğlu; Eric L Hurwitz; Nadège Lemeunier; Jean Dudler; Anne Taylor-Vaisey; Erkin Sönmez Journal: Eur Spine J Date: 2018-02-28 Impact factor: 3.134
Authors: Pierre Côté; Jessica J Wong; Deborah Sutton; Heather M Shearer; Silvano Mior; Kristi Randhawa; Arthur Ameis; Linda J Carroll; Margareta Nordin; Hainan Yu; Gail M Lindsay; Danielle Southerst; Sharanya Varatharajan; Craig Jacobs; Maja Stupar; Anne Taylor-Vaisey; Gabrielle van der Velde; Douglas P Gross; Robert J Brison; Mike Paulden; Carlo Ammendolia; J David Cassidy; Patrick Loisel; Shawn Marshall; Richard N Bohay; John Stapleton; Michel Lacerte; Murray Krahn; Roger Salhany Journal: Eur Spine J Date: 2016-03-16 Impact factor: 3.134
Authors: Francisco Manzano; Manuel Colmenero; Ana María Pérez-Pérez; Delphine Roldán; María del Mar Jiménez-Quintana; María Reyes Mañas; María Angustias Sánchez-Moya; Carmen Guerrero; María Ángeles Moral-Marfil; Emilio Sánchez-Cantalejo; Enrique Fernández-Mondéjar Journal: Intensive Care Med Date: 2014-09-05 Impact factor: 17.440
Authors: J Keech; J Beca; A Eisen; E Kennedy; J Kim; C T Kouroukis; G Darling; S E Ferguson; A Finelli; T M Petrella; J R Perry; K Chan; S Gavura Journal: Curr Oncol Date: 2019-04-01 Impact factor: 3.677
Authors: Lalla Aïda Guindo; Monika Wagner; Rob Baltussen; Donna Rindress; Janine van Til; Paul Kind; Mireille M Goetghebeur Journal: Cost Eff Resour Alloc Date: 2012-07-18